|
2024
|
G/S
|
Promoting public awareness of the need for education, research, treatment and a cure for diseases... |
|
|
G/S
|
pharmaceutical and biological preparations used in the treatment of diseases, disorders or condit... |
|
2023
|
Invention
|
Sustained release compositions of 4-aminopyridine.
The present invention generally relates to su... |
|
|
Invention
|
Methods of using sustained release aminopyridine compositions.
A pharmaceutical composition whic... |
|
|
Invention
|
Sustained release aminopyridine composition.
A pharmaceutical composition which comprises a ther... |
|
2022
|
G/S
|
Providing medical and scientific research information in the field of clinical trials for pharmac... |
|
|
G/S
|
Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment... |
|
|
Invention
|
Use of neuregulin to treat peripheral nerve injury.
The disclosure provides compositions and met... |
|
2021
|
G/S
|
Pharmaceutical and biological preparations used in the treatment of spinal cord injuries, multipl... |
|
|
G/S
|
Medical devices, namely, drug delivery system in the nature of an oral inhaler that facilitates t... |
|
2020
|
Invention
|
Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart fa... |
|
|
Invention
|
Methods for cardiomyocyte survival, proliferation or differentiation by nrg-2.
The invention fea... |
|
|
Invention
|
Method for achieving desired glial growth factor 2 plasma levels.
The present invention relates ... |
|
|
Invention
|
Compositions and methods for treatment during non-acute periods following cns neurological injury... |
|
|
Invention
|
Methods and compositions for treating cns injury. Disclosed herein are methods and compositions f... |
|
|
Invention
|
Methods for treating an impairment in gait and/or balance in patients with multiple sclerosis usi... |
|
2019
|
Invention
|
Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients... |
|
|
Invention
|
Durable treatment with 4-aminopyridine in patients with demyelination.
Disclosed herein are meth... |
|
|
Invention
|
Compositions and methods including a recombinant human mab that promotes cns remyelination.
Anti... |
|
|
Invention
|
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart... |
|
|
Invention
|
Water-soluble acetaminophen analogs. The present invention provides water-soluble acetaminophen p... |
|
|
Invention
|
Compositions and methods for the treatment of cns injuries.
The present invention is directed to... |
|
|
Invention
|
Carbonate prodrugs and methods of using the same. The present invention provides carbonate prodru... |
|
|
Invention
|
Methods for detecting cardiac damage. The present invention relates to a method for detecting hea... |
|
2018
|
Invention
|
Methods for cardiomyocyte survival, proliferation or differentiation by nrg-2. The invention feat... |
|
|
Invention
|
Use of a neuregulin to treat peripheral nerve injury.
Embodiments of the invention are directed ... |
|
|
Invention
|
Method, apparatus and software for identifying responders in a clinical environment.
A process f... |
|
|
G/S
|
Providing campaigns featuring information to promote public awareness regarding Parkinson's disea... |
|
|
Invention
|
Hepatoprotectant acetaminophen mutual prodrugs.
The present invention provides hepatoprotectant ... |
|
2017
|
Invention
|
Methods of reducing extravasation of inflammatory cells. A method for modifying access of cells t... |
|
|
G/S
|
Pharmaceutical products, namely, pharmaceutical and biological preparations for the treatment of ... |
|
|
G/S
|
Pharmaceutical and biological preparations used in the treatment of diseases, disorders or condit... |
|
2016
|
G/S
|
Medical devices, namely inhaler and nebulizer delivery devices that facilitate delivery of pharma... |
|
2014
|
G/S
|
Pharmaceutical products; pharmaceutical and biological preparations used in the treatment of dise... |
|
2013
|
G/S
|
Pharmaceutical and biological compositions used in the treatment of neurological diseases, disord... |
|
2011
|
G/S
|
Pharmaceutical preparations for the treatment of function in neurological, neurotrauma, autoimmun... |
|
|
G/S
|
Pharmaceutical and biological preparations used in the treatment of neurological diseases, disord... |
|
2009
|
G/S
|
Pharmaceutical and biological preparations, products and formulations used in the treatment of sp... |
|
2004
|
G/S
|
Pharmaceutical preparations used in the treatment of spinal cord injuries, multiple sclerosis and... |
|
2001
|
G/S
|
pharmaceuticals. |
